{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T09:15:54Z","timestamp":1787822154115,"version":"build-2784847793"},"reference-count":100,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,1,15]],"date-time":"2025-01-15T00:00:00Z","timestamp":1736899200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,1,15]],"date-time":"2025-01-15T00:00:00Z","timestamp":1736899200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Rheumatol Int"],"DOI":"10.1007\/s00296-024-05784-1","type":"journal-article","created":{"date-parts":[[2025,1,15]],"date-time":"2025-01-15T05:30:40Z","timestamp":1736919040000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Late-onset Systemic Lupus Erythematosus"],"prefix":"10.1007","volume":"45","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1278-6042","authenticated-orcid":false,"given":"Prakashini","family":"Mruthyunjaya","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4631-311X","authenticated-orcid":false,"given":"Sakir","family":"Ahmed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7407-5505","authenticated-orcid":false,"given":"Aliya","family":"Botabekova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3261-1036","authenticated-orcid":false,"given":"Chokan","family":"Baimukhamedov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4188-8486","authenticated-orcid":false,"given":"Olena","family":"Zimba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,1,15]]},"reference":[{"key":"5784_CR1","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1038\/s41569-018-0064-2","volume":"15","author":"L Ferrucci","year":"2018","unstructured":"Ferrucci L, Fabbri E (2018) Inflammageing: chronic inflammation in ageing, cardiovascular disease, and frailty. Nat Rev Cardiol 15:505\u2013522. https:\/\/doi.org\/10.1038\/s41569-018-0064-2","journal-title":"Nat Rev Cardiol"},{"key":"5784_CR2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41392-023-01451-2","volume":"8","author":"Z Liu","year":"2023","unstructured":"Liu Z, Liang Q, Ren Y et al (2023) Immunosenescence: molecular mechanisms and diseases. Sig Transduct Target Ther 8:1\u201316. https:\/\/doi.org\/10.1038\/s41392-023-01451-2","journal-title":"Sig Transduct Target Ther"},{"key":"5784_CR3","doi-asserted-by":"publisher","first-page":"1218","DOI":"10.3390\/biomedicines11041218","volume":"11","author":"N Nagy","year":"2023","unstructured":"Nagy N, Papp G, G\u00e1sp\u00e1r-Kiss E et al (2023) Changes in clinical manifestations and course of systemic Lupus Erythematosus and secondary antiphospholipid syndrome over three decades. Biomedicines 11:1218. https:\/\/doi.org\/10.3390\/biomedicines11041218","journal-title":"Biomedicines"},{"key":"5784_CR4","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1007\/s10067-016-3492-6","volume":"36","author":"T Tarr","year":"2017","unstructured":"Tarr T, Papp G, Nagy N et al (2017) Chronic high-dose glucocorticoid therapy triggers the development of chronic organ damage and worsens disease outcome in systemic lupus erythematosus. Clin Rheumatol 36:327\u2013333. https:\/\/doi.org\/10.1007\/s10067-016-3492-6","journal-title":"Clin Rheumatol"},{"key":"5784_CR5","doi-asserted-by":"publisher","first-page":"87","DOI":"10.56543\/aaeeu.2024.3.2.05","volume":"3","author":"N Gokcen","year":"2024","unstructured":"Gokcen N, Cefle A (2024) Clinical features of late-onset systemis lupus erythematosus. Anti-Aging East Europe 3:87\u201395. https:\/\/doi.org\/10.56543\/aaeeu.2024.3.2.05","journal-title":"Anti-Aging East Europe"},{"key":"5784_CR6","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.ejim.2023.02.004","volume":"112","author":"M Zen","year":"2023","unstructured":"Zen M, Salmaso L, Barbiellini Amidei C et al (2023) Mortality and causes of death in systemic lupus erythematosus over the last decade: data from a large population-based study. Eur J Intern Med 112:45\u201351. https:\/\/doi.org\/10.1016\/j.ejim.2023.02.004","journal-title":"Eur J Intern Med"},{"key":"5784_CR7","doi-asserted-by":"publisher","first-page":"3899","DOI":"10.1093\/rheumatology\/kead148","volume":"62","author":"C Kavadichanda","year":"2023","unstructured":"Kavadichanda C, Ganapathy S, Kounassegarane D et al (2023) Clusters based on demography, disease phenotype, and autoantibody status predicts mortality in lupus: data from Indian lupus cohort (INSPIRE). Rheumatology 62:3899\u20133908. https:\/\/doi.org\/10.1093\/rheumatology\/kead148","journal-title":"Rheumatology"},{"key":"5784_CR8","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1177\/0961203308089695","volume":"17","author":"S Appenzeller","year":"2008","unstructured":"Appenzeller S, Pereira D, Costallat L (2008) Greater accrual damage in late-onset systemic lupus erythematosus: a long-term follow-up study. Lupus 17:1023\u20131028. https:\/\/doi.org\/10.1177\/0961203308089695","journal-title":"Lupus"},{"key":"5784_CR9","doi-asserted-by":"publisher","first-page":"1409","DOI":"10.1007\/s00296-011-1999-3","volume":"31","author":"AY Gasparyan","year":"2011","unstructured":"Gasparyan AY, Ayvazyan L, Blackmore H, Kitas GD (2011) Writing a narrative biomedical review: considerations for authors, peer reviewers, and editors. Rheumatol Int 31:1409\u20131417. https:\/\/doi.org\/10.1007\/s00296-011-1999-3","journal-title":"Rheumatol Int"},{"key":"5784_CR10","doi-asserted-by":"publisher","first-page":"1225","DOI":"10.1007\/s00296-010-1744-3","volume":"32","author":"A Achour","year":"2012","unstructured":"Achour A, Manka\u00ef A, Thabet Y et al (2012) Systemic lupus erythematosus in the elderly. Rheumatol Int 32:1225\u20131229. https:\/\/doi.org\/10.1007\/s00296-010-1744-3","journal-title":"Rheumatol Int"},{"key":"5784_CR11","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1007\/s00296-006-0284-3","volume":"27","author":"M Padovan","year":"2007","unstructured":"Padovan M, Govoni M, Castellino G et al (2007) Late onset systemic lupus erythematosus: no substantial differences using different cut-off ages. Rheumatol Int 27:735. https:\/\/doi.org\/10.1007\/s00296-006-0284-3","journal-title":"Rheumatol Int"},{"key":"5784_CR12","doi-asserted-by":"publisher","first-page":"1053","DOI":"10.1007\/s10067-013-2238-y","volume":"32","author":"A Tomic-Lucic","year":"2013","unstructured":"Tomic-Lucic A, Petrovic R, Radak-Perovic M et al (2013) Late-onset systemic lupus erythematosus: clinical features, course, and prognosis. Clin Rheumatol 32:1053\u20131058. https:\/\/doi.org\/10.1007\/s10067-013-2238-y","journal-title":"Clin Rheumatol"},{"key":"5784_CR13","doi-asserted-by":"crossref","unstructured":"Gaujard S, Broussolle C, Cathebras P et al (2003) Lupus \u00e9ryth\u00e9mateux diss\u00e9min\u00e9 survenant apr\u00e8s 65 ans systemic lupus erythematosus with disease onset at 65 and older. La revue de m\u00e9decine interne","DOI":"10.1016\/S0248-8663(03)00052-3"},{"key":"5784_CR14","doi-asserted-by":"crossref","unstructured":"Lazaro D (2007) Elderly-onset systemic lupus erythematosus. Drugs Aging","DOI":"10.2165\/00002512-200724090-00001"},{"key":"5784_CR15","doi-asserted-by":"publisher","DOI":"10.55563\/clinexprheumatol\/oo5ymg","author":"I Prevete","year":"2021","unstructured":"Prevete I, Iuliano A, Cauli A et al (2021) Similarities and differences between younger and older disease onset patients with newly diagnosed systemic lupus erythematosus. Clin Exp Rheumatol. https:\/\/doi.org\/10.55563\/clinexprheumatol\/oo5ymg","journal-title":"Clin Exp Rheumatol"},{"key":"5784_CR16","doi-asserted-by":"publisher","first-page":"101938","DOI":"10.1016\/j.berh.2024.101938","volume":"37","author":"M Piga","year":"2023","unstructured":"Piga M, Tselios K, Viveiros L et al (2023) Clinical patterns of disease: from early systemic lupus erythematosus to late-onset disease. Best Pract Res Clin Rheumatol 37:101938. https:\/\/doi.org\/10.1016\/j.berh.2024.101938","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"5784_CR17","doi-asserted-by":"publisher","first-page":"1793","DOI":"10.1093\/rheumatology\/keaa477","volume":"60","author":"A Riveros Frutos","year":"2021","unstructured":"Riveros Frutos A, Holgado S, Sanvisens Berg\u00e9 A et al (2021) Late-onset versus early-onset systemic lupus: characteristics and outcome in a national multicentre register (RELESSER). Rheumatology 60:1793\u20131803. https:\/\/doi.org\/10.1093\/rheumatology\/keaa477","journal-title":"Rheumatology"},{"key":"5784_CR18","doi-asserted-by":"publisher","first-page":"955","DOI":"10.1007\/s00296-016-3450-2","volume":"36","author":"S Sousa","year":"2016","unstructured":"Sousa S, Gon\u00e7alves MJ, In\u00eas LS et al (2016) Clinical features and long-term outcomes of systemic lupus erythematosus: comparative data of childhood, adult and late-onset disease in a national register. Rheumatol Int 36:955\u2013960. https:\/\/doi.org\/10.1007\/s00296-016-3450-2","journal-title":"Rheumatol Int"},{"key":"5784_CR19","doi-asserted-by":"publisher","first-page":"788","DOI":"10.1177\/0961203314563134","volume":"24","author":"LJ Catoggio","year":"2015","unstructured":"Catoggio LJ, Soriano ER, Imamura PM et al (2015) Late-onset systemic lupus erythematosus in Latin americans: a distinct subgroup? Lupus 24:788\u2013795. https:\/\/doi.org\/10.1177\/0961203314563134","journal-title":"Lupus"},{"key":"5784_CR20","doi-asserted-by":"publisher","first-page":"1135","DOI":"10.1177\/0961203312450087","volume":"21","author":"M Alonso","year":"2012","unstructured":"Alonso M, Martinez-Vazquez F, De Teran TD et al (2012) Late-onset systemic lupus erythematosus in Northwestern Spain: differences with early-onset systemic lupus erythematosus and literature review. Lupus 21:1135\u20131148. https:\/\/doi.org\/10.1177\/0961203312450087","journal-title":"Lupus"},{"key":"5784_CR21","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1191\/096120300678828109","volume":"9","author":"SJ Pu","year":"2000","unstructured":"Pu SJ, Luo SF, Wu YJJ et al (2000) The clinical features and prognosis of lupus with disease onset at age 65 and older. Lupus 9:96\u2013100. https:\/\/doi.org\/10.1191\/096120300678828109","journal-title":"Lupus"},{"key":"5784_CR22","doi-asserted-by":"publisher","DOI":"10.1007\/s12026-024-09470-z","author":"R Chang","year":"2024","unstructured":"Chang R, Xiang S, Jin Y et al (2024) Hormone and reproductive factors and risk of systemic lupus erythematosus: a mendelian randomized study. Immunol Res. https:\/\/doi.org\/10.1007\/s12026-024-09470-z","journal-title":"Immunol Res"},{"key":"5784_CR23","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1007\/s12026-016-8891-x","volume":"65","author":"LJ Jara","year":"2017","unstructured":"Jara LJ, Medina G, Saavedra MA et al (2017) Prolactin has a pathogenic role in systemic lupus erythematosus. Immunol Res 65:512\u2013523. https:\/\/doi.org\/10.1007\/s12026-016-8891-x","journal-title":"Immunol Res"},{"key":"5784_CR24","doi-asserted-by":"publisher","first-page":"2044","DOI":"10.1111\/jgs.12533","volume":"61","author":"R Nisihara","year":"2013","unstructured":"Nisihara R, Menine Kubis M, Rodrigues PCS et al (2013) Antinuclear Antibodies and rheumatoid factor positivity in healthy Elderly adults: a cross-sectional study in 336 individuals. J Am Geriatr Soc 61:2044\u20132046. https:\/\/doi.org\/10.1111\/jgs.12533","journal-title":"J Am Geriatr Soc"},{"key":"5784_CR25","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1093\/rheumatology\/keg096","volume":"42","author":"JPA Ioannidis","year":"2003","unstructured":"Ioannidis JPA (2003) Evaluation of the association of autoantibodies with mortality in the very elderly: a cohort study. Rheumatology 42:357\u2013361. https:\/\/doi.org\/10.1093\/rheumatology\/keg096","journal-title":"Rheumatology"},{"key":"5784_CR26","doi-asserted-by":"publisher","unstructured":"Viveiros L, Neves A, Gouveia T, Isenberg DA (2024) A large cohort comparison of very late-onset systemic lupus erythematosus with younger-onset patients. Clin Exp Rheumatol 42(7):1480\u20131486. https:\/\/doi.org\/10.55563\/clinexprheumatol\/jgsyos","DOI":"10.55563\/clinexprheumatol\/jgsyos"},{"key":"5784_CR27","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1097\/01.md.0000147737.57861.7c","volume":"83","author":"J Boddaert","year":"2004","unstructured":"Boddaert J, Huong DLT, Amoura Z et al (2004) Late-Onset systemic lupus erythematosus: a personal series of 47 patients and pooled analysis of 714 cases in the literature. Medicine 83:348\u2013359. https:\/\/doi.org\/10.1097\/01.md.0000147737.57861.7c","journal-title":"Medicine"},{"key":"5784_CR28","doi-asserted-by":"publisher","first-page":"1283","DOI":"10.1007\/s00296-024-05579-4","volume":"44","author":"J Kosa\u0142ka-W\u0119giel","year":"2024","unstructured":"Kosa\u0142ka-W\u0119giel J, Dziedzic R, Siwiec-Ko\u017alik A et al (2024) Clinical and laboratory characteristics of early-onset and delayed-onset lupus nephritis patients: a single-center retrospective study. Rheumatol Int 44:1283\u20131294. https:\/\/doi.org\/10.1007\/s00296-024-05579-4","journal-title":"Rheumatol Int"},{"key":"5784_CR29","doi-asserted-by":"publisher","unstructured":"Figueroa-Parra G, Meade-Aguilar JA, Hulshizer CA et al (2023) Multimorbidity in systemic lupus erythematosus in a population-based cohort: the lupus midwest network. Rheumatology, kead617. https:\/\/doi.org\/10.1093\/rheumatology\/kead617","DOI":"10.1093\/rheumatology\/kead617"},{"key":"5784_CR30","doi-asserted-by":"crossref","unstructured":"Arnaud L, Mathian A, Boddaert J, Amoura Z (2012) Late-onset systemic lupus erythematosus. Drugs Aging","DOI":"10.2165\/11598550-000000000-00000"},{"key":"5784_CR31","first-page":"2365","volume":"30","author":"S Uaratanawong","year":"2003","unstructured":"Uaratanawong S, Deesomchoke U, Lertmaharit S, Uaratanawong S (2003) Bone mineral density in premenopausal women with systemic lupus erythematosus. J Rhuematol 30:2365\u20132368","journal-title":"J Rhuematol"},{"key":"5784_CR32","doi-asserted-by":"publisher","unstructured":"Barbulescu A, Vreju FA (2015) Osteoporosis in systemic lupus erythematosus - correlations with disease activity and organ damage. Curr Health Sci J 109\u2013114. https:\/\/doi.org\/10.12865\/CHSJ.41.02.04","DOI":"10.12865\/CHSJ.41.02.04"},{"key":"5784_CR33","doi-asserted-by":"publisher","first-page":"1185","DOI":"10.1093\/rheumatology\/kem105","volume":"46","author":"K Almehed","year":"2007","unstructured":"Almehed K, Forsblad d\u2019Elia H, Kvist G et al (2007) Prevalence and risk factors of osteoporosis in female SLE patients\u2014extended report. Rheumatology 46:1185\u20131190. https:\/\/doi.org\/10.1093\/rheumatology\/kem105","journal-title":"Rheumatology"},{"key":"5784_CR34","doi-asserted-by":"publisher","first-page":"2044","DOI":"10.1002\/art.21110","volume":"52","author":"IEM Bultink","year":"2005","unstructured":"Bultink IEM, Lems WF, Kostense PJ et al (2005) Prevalence of and risk factors for low bone mineral density and vertebral fractures in patients with systemic lupus erythematosus. Arthr Rhuem 52:2044\u20132050. https:\/\/doi.org\/10.1002\/art.21110","journal-title":"Arthr Rhuem"},{"key":"5784_CR35","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1007\/s10067-008-0984-z","volume":"28","author":"C Mendoza-Pinto","year":"2009","unstructured":"Mendoza-Pinto C, Garc\u00eda-Carrasco M, Sandoval-Cruz H et al (2009) Risks factors for low bone mineral density in pre-menopausal Mexican women with systemic lupus erythematosus. Clin Rheumatol 28:65\u201370. https:\/\/doi.org\/10.1007\/s10067-008-0984-z","journal-title":"Clin Rheumatol"},{"key":"5784_CR36","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1007\/s10067-003-0743-0","volume":"22","author":"M Boyanov","year":"2003","unstructured":"Boyanov M, Robeva R, Popivanov P (2003) Bone mineral density changes in women with systemic lupus erythematosus. Clin Rheumatol 22:318\u2013323. https:\/\/doi.org\/10.1007\/s10067-003-0743-0","journal-title":"Clin Rheumatol"},{"key":"5784_CR37","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1007\/s12026-017-8906-2","volume":"65","author":"N Katz-Agranov","year":"2017","unstructured":"Katz-Agranov N, Zandman-Goddard G (2017) The microbiome and systemic lupus erythematosus. Immunol Res 65:432\u2013437. https:\/\/doi.org\/10.1007\/s12026-017-8906-2","journal-title":"Immunol Res"},{"key":"5784_CR38","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1186\/s13075-018-1760-3","volume":"20","author":"L Song","year":"2018","unstructured":"Song L, Wang Y, Zhang J et al (2018) The risks of cancer development in systemic lupus erythematosus (SLE) patients: a systematic review and meta-analysis. Arthritis Res Ther 20:270. https:\/\/doi.org\/10.1186\/s13075-018-1760-3","journal-title":"Arthritis Res Ther"},{"key":"5784_CR39","doi-asserted-by":"publisher","first-page":"860794","DOI":"10.3389\/fonc.2022.860794","volume":"12","author":"M Zhang","year":"2022","unstructured":"Zhang M, Wang Y, Wang Y et al (2022) Association between systemic Lupus Erythematosus and Cancer Morbidity and Mortality: findings from Cohort studies. Front Oncol 12:860794. https:\/\/doi.org\/10.3389\/fonc.2022.860794","journal-title":"Front Oncol"},{"key":"5784_CR40","doi-asserted-by":"publisher","DOI":"10.1007\/s00296-024-05623-3","author":"J Kosa\u0142ka-W\u0119giel","year":"2024","unstructured":"Kosa\u0142ka-W\u0119giel J, Pacholczak-Madej R, Dziedzic R et al (2024) Malignancy in systemic lupus erythematosus: relation to disease characteristics in 92 patients\u2013 a single center retrospective study. Rheumatol Int. https:\/\/doi.org\/10.1007\/s00296-024-05623-3","journal-title":"Rheumatol Int"},{"key":"5784_CR41","doi-asserted-by":"publisher","first-page":"1400","DOI":"10.1002\/art.40930","volume":"71","author":"M Aringer","year":"2019","unstructured":"Aringer M, Costenbader K, Daikh D et al (2019) 2019 European League Against Rheumatism\/American College of Rheumatology Classification Criteria for systemic Lupus Erythematosus. Arthritis Rheumatol 71:1400\u20131412. https:\/\/doi.org\/10.1002\/art.40930","journal-title":"Arthritis Rheumatol"},{"key":"5784_CR42","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1007\/s00296-020-04764-5","volume":"41","author":"S Ahmed","year":"2021","unstructured":"Ahmed S, Gasparyan AY, Zimba O (2021) Comorbidities in rheumatic diseases need special consideration during the COVID-19 pandemic. Rheumatol Int 41:243\u2013256. https:\/\/doi.org\/10.1007\/s00296-020-04764-5","journal-title":"Rheumatol Int"},{"key":"5784_CR43","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.idc.2022.11.001","volume":"37","author":"Y Abul","year":"2023","unstructured":"Abul Y, Leeder C, Gravenstein S (2023) Epidemiology and clinical presentation of COVID-19 in older adults. Infect Dis Clin N Am 37:1\u201326. https:\/\/doi.org\/10.1016\/j.idc.2022.11.001","journal-title":"Infect Dis Clin N Am"},{"key":"5784_CR44","doi-asserted-by":"publisher","first-page":"1445","DOI":"10.1093\/ageing\/afab103","volume":"50","author":"S-C Shao","year":"2021","unstructured":"Shao S-C, Lai C-C, Chen Y-H et al (2021) Prevalence, incidence and mortality of delirium in patients with COVID-19: a systematic review and meta-analysis. Age Ageing 50:1445\u20131453. https:\/\/doi.org\/10.1093\/ageing\/afab103","journal-title":"Age Ageing"},{"key":"5784_CR45","doi-asserted-by":"publisher","first-page":"1309","DOI":"10.1016\/j.jaci.2020.03.017","volume":"145","author":"CE Gustafson","year":"2020","unstructured":"Gustafson CE, Kim C, Weyand CM, Goronzy JJ (2020) Influence of immune aging on vaccine responses. J Allergy Clin Immunol 145:1309\u20131321. https:\/\/doi.org\/10.1016\/j.jaci.2020.03.017","journal-title":"J Allergy Clin Immunol"},{"key":"5784_CR46","doi-asserted-by":"publisher","first-page":"628","DOI":"10.3390\/cells10030628","volume":"10","author":"W Wang","year":"2021","unstructured":"Wang W, Thomas R, Oh J, Su D-M (2021) Thymic aging may be Associated with COVID-19 pathophysiology in the Elderly. Cells 10:628. https:\/\/doi.org\/10.3390\/cells10030628","journal-title":"Cells"},{"key":"5784_CR47","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1016\/j.ijid.2021.10.033","volume":"113","author":"X Hou","year":"2021","unstructured":"Hou X, Wang G, Fan W et al (2021) T-cell receptor repertoires as potential diagnostic markers for patients with COVID-19. Int J Infect Dis 113:308\u2013317. https:\/\/doi.org\/10.1016\/j.ijid.2021.10.033","journal-title":"Int J Infect Dis"},{"key":"5784_CR48","doi-asserted-by":"publisher","first-page":"e13102","DOI":"10.1111\/sji.13102","volume":"94","author":"L Cunningham","year":"2021","unstructured":"Cunningham L, Kimber I, Basketter D et al (2021) Perforin, COVID-19 and a possible pathogenic auto-inflammatory feedback loop. Scand J Immunol 94:e13102. https:\/\/doi.org\/10.1111\/sji.13102","journal-title":"Scand J Immunol"},{"key":"5784_CR49","doi-asserted-by":"publisher","first-page":"996","DOI":"10.1016\/j.cell.2020.09.038","volume":"183","author":"C Rydyznski Moderbacher","year":"2020","unstructured":"Rydyznski Moderbacher C, Ramirez SI, Dan JM et al (2020) Antigen-Specific Adaptive immunity to SARS-CoV-2 in Acute COVID-19 and associations with Age and Disease Severity. Cell 183:996\u20131012e19. https:\/\/doi.org\/10.1016\/j.cell.2020.09.038","journal-title":"Cell"},{"key":"5784_CR50","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1038\/s41423-020-0402-2","volume":"17","author":"M Zheng","year":"2020","unstructured":"Zheng M, Gao Y, Wang G et al (2020) Functional exhaustion of antiviral lymphocytes in COVID-19 patients. Cell Mol Immunol 17:533\u2013535. https:\/\/doi.org\/10.1038\/s41423-020-0402-2","journal-title":"Cell Mol Immunol"},{"key":"5784_CR51","doi-asserted-by":"publisher","first-page":"1069","DOI":"10.1016\/j.arr.2013.04.003","volume":"12","author":"J Hazeldine","year":"2013","unstructured":"Hazeldine J, Lord JM (2013) The impact of ageing on natural killer cell function and potential consequences for health in older adults. Ageing Res Rev 12:1069\u20131078. https:\/\/doi.org\/10.1016\/j.arr.2013.04.003","journal-title":"Ageing Res Rev"},{"key":"5784_CR52","doi-asserted-by":"publisher","first-page":"2761","DOI":"10.1007\/s10067-023-06694-6","volume":"42","author":"P Mv","year":"2023","unstructured":"Mv P, Auanassova A, Yessirkepov M et al (2023) New-onset systemic vasculitis following SARS-CoV-2 infection and vaccination: the trigger, phenotype, and outcome. Clin Rheumatol 42:2761\u20132775. https:\/\/doi.org\/10.1007\/s10067-023-06694-6","journal-title":"Clin Rheumatol"},{"key":"5784_CR53","doi-asserted-by":"publisher","first-page":"e2336120","DOI":"10.1001\/jamanetworkopen.2023.36120","volume":"6","author":"SH Lim","year":"2023","unstructured":"Lim SH, Ju HJ, Han JH et al (2023) Autoimmune and autoinflammatory connective tissue disorders following COVID-19. JAMA Netw Open 6:e2336120. https:\/\/doi.org\/10.1001\/jamanetworkopen.2023.36120","journal-title":"JAMA Netw Open"},{"key":"5784_CR54","doi-asserted-by":"publisher","first-page":"e15011","DOI":"10.1111\/1756-185X.15011","volume":"27","author":"C Baimukhamedov","year":"2024","unstructured":"Baimukhamedov C, Togizbayev G, Mirakhmedova K et al (2024) Increasing autoimmune rheumatic diseases as a consequence of the COVID-19 pandemic: a hypothesis or fact? Int J Rheum Dis 27:e15011. https:\/\/doi.org\/10.1111\/1756-185X.15011","journal-title":"Int J Rheum Dis"},{"key":"5784_CR55","doi-asserted-by":"publisher","first-page":"2371","DOI":"10.1111\/1756-185X.14893","volume":"26","author":"P Mv","year":"2023","unstructured":"Mv P, Ahmed S (2023) COVID-19 vaccination and autoimmunity: causality, precipitation or chance association? Int J Rheum Dis 26:2371\u20132372. https:\/\/doi.org\/10.1111\/1756-185X.14893","journal-title":"Int J Rheum Dis"},{"key":"5784_CR56","doi-asserted-by":"publisher","first-page":"1003","DOI":"10.1007\/s00296-024-05582-9","volume":"44","author":"A Auanassova","year":"2024","unstructured":"Auanassova A, Yessirkepov M, Zimba O et al (2024) Diagnostic delays in systemic vasculitides. Rheumatol Int 44:1003\u20131011. https:\/\/doi.org\/10.1007\/s00296-024-05582-9","journal-title":"Rheumatol Int"},{"key":"5784_CR57","doi-asserted-by":"publisher","first-page":"14","DOI":"10.21037\/acr-21-55","volume":"6","author":"L Ramachandran","year":"2022","unstructured":"Ramachandran L, Dontaraju VS, Troyer J, Sahota J (2022) New onset systemic lupus erythematosus after COVID-19 infection: a case report. AME Case Rep 6:14. https:\/\/doi.org\/10.21037\/acr-21-55","journal-title":"AME Case Rep"},{"key":"5784_CR58","doi-asserted-by":"publisher","first-page":"102154","DOI":"10.1016\/j.eclinm.2023.102154","volume":"63","author":"K Peng","year":"2023","unstructured":"Peng K, Li X, Yang D et al (2023) Risk of autoimmune diseases following COVID-19 and the potential protective effect from vaccination: a population-based cohort study. eClinicalMedicine 63:102154. https:\/\/doi.org\/10.1016\/j.eclinm.2023.102154","journal-title":"eClinicalMedicine"},{"key":"5784_CR59","doi-asserted-by":"publisher","first-page":"101783","DOI":"10.1016\/j.eclinm.2022.101783","volume":"56","author":"R Chang","year":"2023","unstructured":"Chang R, Yen-Ting Chen T, Wang S-I et al (2023) Risk of autoimmune diseases in patients with COVID-19: a retrospective cohort study. eClinicalMedicine 56:101783. https:\/\/doi.org\/10.1016\/j.eclinm.2022.101783","journal-title":"eClinicalMedicine"},{"key":"5784_CR60","doi-asserted-by":"publisher","first-page":"1716","DOI":"10.3390\/ijms23031716","volume":"23","author":"E Gusev","year":"2022","unstructured":"Gusev E, Sarapultsev A, Solomatina L, Chereshnev V (2022) SARS-CoV-2-Specific Immune response and the pathogenesis of COVID-19. IJMS 23:1716. https:\/\/doi.org\/10.3390\/ijms23031716","journal-title":"IJMS"},{"key":"5784_CR61","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1007\/s11926-023-01110-z","volume":"25","author":"M Pappa","year":"2023","unstructured":"Pappa M, Panagiotopoulos A, Thomas K, Fanouriakis A (2023) Systemic lupus erythematosus and COVID-19. Curr Rheumatol Rep 25:192\u2013203. https:\/\/doi.org\/10.1007\/s11926-023-01110-z","journal-title":"Curr Rheumatol Rep"},{"key":"5784_CR62","doi-asserted-by":"publisher","unstructured":"Parodis I, Girard-Guyonvarc\u2019h C, Arnaud L et al (2023) EULAR recommendations for the non-pharmacological management of systemic lupus erythematosus and systemic sclerosis. Ann Rheum Dis, ard-2023-224416. https:\/\/doi.org\/10.1136\/ard-2023-224416","DOI":"10.1136\/ard-2023-224416"},{"key":"5784_CR63","doi-asserted-by":"publisher","first-page":"e003476","DOI":"10.1136\/rmdopen-2023-003476","volume":"9","author":"L Kawka","year":"2023","unstructured":"Kawka L, Sarmiento-Monroy J-C, Mertz P et al (2023) Assessment and personalised advice for fatigue in systemic lupus erythematosus using an innovative digital tool: the Lupus Expert system for the Assessment of Fatigue (LEAF) study. RMD Open 9:e003476. https:\/\/doi.org\/10.1136\/rmdopen-2023-003476","journal-title":"RMD Open"},{"key":"5784_CR64","doi-asserted-by":"publisher","first-page":"e0134451","DOI":"10.1371\/journal.pone.0134451","volume":"10","author":"D Xu","year":"2015","unstructured":"Xu D, You X, Wang Z et al (2015) Chinese Systemic Lupus Erythematosus Treatment and Research Group Registry VI: effect of cigarette smoking on the clinical phenotype of Chinese patients with systemic Lupus Erythematosus. PLoS ONE 10:e0134451. https:\/\/doi.org\/10.1371\/journal.pone.0134451","journal-title":"PLoS ONE"},{"key":"5784_CR65","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1159\/000276370","volume":"79","author":"N Navarrete-Navarrete","year":"2010","unstructured":"Navarrete-Navarrete N, Peralta-Ram\u00edrez MI, Sabio-S\u00e1nchez JM et al (2010) Efficacy of cognitive behavioural therapy for the Treatment of Chronic Stress in patients with Lupus Erythematosus: a Randomized Controlled Trial. Psychother Psychosom 79:107\u2013115. https:\/\/doi.org\/10.1159\/000276370","journal-title":"Psychother Psychosom"},{"key":"5784_CR66","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1111\/exd.12428","volume":"23","author":"S Zahn","year":"2014","unstructured":"Zahn S, Graef M, Patsinakidis N et al (2014) Ultraviolet light protection by a sunscreen prevents interferon-driven skin inflammation in cutaneous lupus erythematosus. Exp Dermatol 23:516\u2013518. https:\/\/doi.org\/10.1111\/exd.12428","journal-title":"Exp Dermatol"},{"key":"5784_CR67","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/j.ctim.2018.09.001","volume":"41","author":"KR Middleton","year":"2018","unstructured":"Middleton KR, Haaz Moonaz S, Hasni SA et al (2018) Yoga for systemic lupus erythematosus (SLE): clinician experiences and qualitative perspectives from students and yoga instructors living with SLE. Complement Ther Med 41:111\u2013117. https:\/\/doi.org\/10.1016\/j.ctim.2018.09.001","journal-title":"Complement Ther Med"},{"key":"5784_CR68","doi-asserted-by":"publisher","first-page":"884","DOI":"10.1177\/0961203320928423","volume":"29","author":"H Kankaya","year":"2020","unstructured":"Kankaya H, Karadakovan A (2020) Effects of web-based education and counselling for patients with systemic lupus erythematosus: self-efficacy, fatigue and assessment of care. Lupus 29:884\u2013891. https:\/\/doi.org\/10.1177\/0961203320928423","journal-title":"Lupus"},{"key":"5784_CR69","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1177\/0961203319841435","volume":"28","author":"M Fangtham","year":"2019","unstructured":"Fangtham M, Kasturi S, Bannuru RR et al (2019) Non-pharmacologic therapies for systemic lupus erythematosus. Lupus 28:703\u2013712. https:\/\/doi.org\/10.1177\/0961203319841435","journal-title":"Lupus"},{"key":"5784_CR70","doi-asserted-by":"publisher","first-page":"838","DOI":"10.1002\/art.21605","volume":"53","author":"MRPD Carvalho","year":"2005","unstructured":"Carvalho MRPD, Sato EI, Tebexreni AS et al (2005) Effects of supervised cardiovascular training program on exercise tolerance, aerobic capacity, and quality of life in patients with systemic lupus erythematosus. Arthr Rhuem 53:838\u2013844. https:\/\/doi.org\/10.1002\/art.21605","journal-title":"Arthr Rhuem"},{"key":"5784_CR71","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1007\/s00296-024-05546-z","volume":"44","author":"A Gomez","year":"2024","unstructured":"Gomez A, Parodis I, Sj\u00f6wall C (2024) Obesity and tobacco smoking are independently associated with poor patient-reported outcomes in SLE: a cross-sectional study. Rheumatol Int 44:851\u2013861. https:\/\/doi.org\/10.1007\/s00296-024-05546-z","journal-title":"Rheumatol Int"},{"key":"5784_CR72","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1002\/art.20533","volume":"51","author":"CM Greco","year":"2004","unstructured":"Greco CM, Rudy TE, Manzi S (2004) Effects of a stress-reduction program on psychological function, pain, and physical function of systemic lupus erythematosus patients: a randomized controlled trial. Arthr Rhuem 51:625\u2013634. https:\/\/doi.org\/10.1002\/art.20533","journal-title":"Arthr Rhuem"},{"key":"5784_CR73","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1007\/s00296-024-05548-x","volume":"44","author":"A Tsoi","year":"2024","unstructured":"Tsoi A, Gomez A, Bostr\u00f6m C et al (2024) Efficacy of lifestyle interventions in the management of systemic lupus erythematosus: a systematic review of the literature. Rheumatol Int 44:765\u2013778. https:\/\/doi.org\/10.1007\/s00296-024-05548-x","journal-title":"Rheumatol Int"},{"key":"5784_CR74","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1007\/s00296-023-05529-6","volume":"44","author":"Y Fedorchenko","year":"2024","unstructured":"Fedorchenko Y, Mahmudov K, Abenov Z et al (2024) Rehabilitation of patients with inflammatory rheumatic diseases and comorbidities: unmet needs. Rheumatol Int 44:583\u2013591. https:\/\/doi.org\/10.1007\/s00296-023-05529-6","journal-title":"Rheumatol Int"},{"key":"5784_CR75","doi-asserted-by":"publisher","first-page":"1799","DOI":"10.1007\/s00296-023-05370-x","volume":"43","author":"SM Sieczkowska","year":"2023","unstructured":"Sieczkowska SM, Smaira FI, Mazzolani BC et al (2023) A randomized controlled trial of an intervention promoting physical activity and healthy eating recommendations in systemic lupus erythematosus: the protocol study living well with Lupus. Rheumatol Int 43:1799\u20131810. https:\/\/doi.org\/10.1007\/s00296-023-05370-x","journal-title":"Rheumatol Int"},{"key":"5784_CR76","doi-asserted-by":"publisher","first-page":"1705","DOI":"10.1177\/09612033211028653","volume":"30","author":"RA Levy","year":"2021","unstructured":"Levy RA, Gonzalez-Rivera T, Khamashta M et al (2021) 10 years of belimumab experience: what have we learnt? Lupus 30:1705\u20131721. https:\/\/doi.org\/10.1177\/09612033211028653","journal-title":"Lupus"},{"key":"5784_CR77","doi-asserted-by":"publisher","first-page":"e000011","DOI":"10.1136\/rmdopen-2014-000011","volume":"1","author":"A Vilas-Boas","year":"2015","unstructured":"Vilas-Boas A, Morais SA, Isenberg DA (2015) Belimumab in systemic lupus erythematosus. RMD Open 1:e000011. https:\/\/doi.org\/10.1136\/rmdopen-2014-000011","journal-title":"RMD Open"},{"key":"5784_CR78","doi-asserted-by":"publisher","first-page":"3918","DOI":"10.1002\/art.30613","volume":"63","author":"R Furie","year":"2011","unstructured":"Furie R, Petri M, Zamani O et al (2011) A phase III, randomized, placebo-controlled study of belimumab, a monoclonal antibody that inhibits B lymphocyte stimulator, in patients with systemic lupus erythematosus. Arthr Rhuem 63:3918\u20133930. https:\/\/doi.org\/10.1002\/art.30613","journal-title":"Arthr Rhuem"},{"key":"5784_CR79","doi-asserted-by":"publisher","first-page":"1117","DOI":"10.1056\/NEJMoa2001180","volume":"383","author":"R Furie","year":"2020","unstructured":"Furie R, Rovin BH, Houssiau F et al (2020) Two-Year, Randomized, Controlled Trial of Belimumab in Lupus Nephritis. N Engl J Med 383:1117\u20131128. https:\/\/doi.org\/10.1056\/NEJMoa2001180","journal-title":"N Engl J Med"},{"key":"5784_CR80","doi-asserted-by":"publisher","first-page":"e000830","DOI":"10.1136\/lupus-2022-000830","volume":"10","author":"D D\u2019Cruz","year":"2023","unstructured":"D\u2019Cruz D, Eriksson G, Green Y et al (2023) Safety and efficacy of belimumab in older adults with SLE: results of an integrated analysis of clinical trial data. Lupus Sci Med 10:e000830. https:\/\/doi.org\/10.1136\/lupus-2022-000830","journal-title":"Lupus Sci Med"},{"key":"5784_CR81","doi-asserted-by":"publisher","DOI":"10.1007\/s00296-024-05589-2","author":"M Ja\u00efs","year":"2024","unstructured":"Ja\u00efs M, Roblot P, Maillot F et al (2024) Belimumab corticosteroid-sparing treatment in systemic lupus erythematosus: a real-life observational study (BESST study). Rheumatol Int. https:\/\/doi.org\/10.1007\/s00296-024-05589-2","journal-title":"Rheumatol Int"},{"key":"5784_CR82","doi-asserted-by":"publisher","first-page":"e30393","DOI":"10.1016\/j.heliyon.2024.e30393","volume":"10","author":"L Peng-Cheng","year":"2024","unstructured":"Peng-Cheng L, Meng-Na L, Jian-Bin L et al (2024) Advancements on the impact of hydroxychloroquine in systemic lupus erythematosus. Heliyon 10:e30393. https:\/\/doi.org\/10.1016\/j.heliyon.2024.e30393","journal-title":"Heliyon"},{"key":"5784_CR83","unstructured":"Yam JC, Kwok AK (2006) Ocular toxicity of hydroxychloroquine. Hong Kong Med J 12(4):294\u2013304"},{"key":"5784_CR84","doi-asserted-by":"publisher","first-page":"e2410677","DOI":"10.1001\/jamanetworkopen.2024.10677","volume":"7","author":"AM Jorge","year":"2024","unstructured":"Jorge AM, Melles RB, Marmor MF et al (2024) Risk factors for Hydroxychloroquine Retinopathy and its subtypes. JAMA Netw Open 7:e2410677. https:\/\/doi.org\/10.1001\/jamanetworkopen.2024.10677","journal-title":"JAMA Netw Open"},{"key":"5784_CR85","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1136\/ard-2023-224762","volume":"83","author":"A Fanouriakis","year":"2024","unstructured":"Fanouriakis A, Kostopoulou M, Andersen J et al (2024) EULAR recommendations for the management of systemic lupus erythematosus: 2023 update. Ann Rheum Dis 83:15\u201329. https:\/\/doi.org\/10.1136\/ard-2023-224762","journal-title":"Ann Rheum Dis"},{"key":"5784_CR86","doi-asserted-by":"publisher","first-page":"2191","DOI":"10.1007\/s40620-023-01733-6","volume":"36","author":"IR Rao","year":"2023","unstructured":"Rao IR, Kolakemar A, Shenoy SV et al (2023) Hydroxychloroquine in nephrology: current status and future directions. J Nephrol 36:2191\u20132208. https:\/\/doi.org\/10.1007\/s40620-023-01733-6","journal-title":"J Nephrol"},{"key":"5784_CR87","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1186\/s13075-020-02282-0","volume":"22","author":"R Fernandez-Ruiz","year":"2020","unstructured":"Fernandez-Ruiz R, Bornkamp N, Kim MY et al (2020) Discontinuation of hydroxychloroquine in older patients with systemic lupus erythematosus: a multicenter retrospective study. Arthritis Res Therapy 22:191. https:\/\/doi.org\/10.1186\/s13075-020-02282-0","journal-title":"Arthritis Res Therapy"},{"key":"5784_CR88","unstructured":"Study details | Effects of stopping hydroxychloroquine in elderly lupus disease | ClinicalTrials.gov. https:\/\/clinicaltrials.gov\/study\/NCT05799378. Accessed 7 Jul 2024"},{"key":"5784_CR89","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1111\/imj.15908","volume":"53","author":"JL Fairley","year":"2023","unstructured":"Fairley JL, Nikpour M, Mack HG et al (2023) How toxic is an old friend? A review of the safety of hydroxychloroquine in clinical practice. Intern Med J 53:311\u2013317. https:\/\/doi.org\/10.1111\/imj.15908","journal-title":"Intern Med J"},{"key":"5784_CR90","doi-asserted-by":"publisher","unstructured":"Yuan S, Larsson SC (2023) Epidemiology of Sarcopenia: prevalence, risk factors, and consequences. Metabolism Clin Exp 144. https:\/\/doi.org\/10.1016\/j.metabol.2023.155533","DOI":"10.1016\/j.metabol.2023.155533"},{"key":"5784_CR91","unstructured":"Santos MJ, Vinagre F, Canas da Silva J, Gil V, Fonseca JE (2011) Body composition phenotypes in systemic lupus erythematosus and rheumatoid arthritis: a comparative study of Caucasian female patients. Clin Exp Rheumatol 29(3):470\u2013476"},{"key":"5784_CR92","doi-asserted-by":"publisher","first-page":"901","DOI":"10.2147\/CLEP.S416778","volume":"15","author":"Q Su","year":"2023","unstructured":"Su Q, Jin C, Yang Y et al (2023) Association between Autoimmune diseases and Sarcopenia: a two-sample mendelian randomization study. Clin Epidemiol 15:901\u2013910. https:\/\/doi.org\/10.2147\/CLEP.S416778","journal-title":"Clin Epidemiol"},{"key":"5784_CR93","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.1177\/0961203318758504","volume":"27","author":"LPC Seguro","year":"2018","unstructured":"Seguro LPC, Paupitz JA, Caparbo VF et al (2018) Increased visceral adipose tissue and altered adiposity distribution in premenopausal lupus patients: correlation with cardiovascular risk factors. Lupus 27:1001\u20131006. https:\/\/doi.org\/10.1177\/0961203318758504","journal-title":"Lupus"},{"key":"5784_CR94","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1136\/ard.2004.023200","volume":"65","author":"E Casado","year":"2006","unstructured":"Casado E (2006) Antimalarial myopathy: an underdiagnosed complication? Prospective longitudinal study of 119 patients. Ann Rheum Dis 65:385\u2013390. https:\/\/doi.org\/10.1136\/ard.2004.023200","journal-title":"Ann Rheum Dis"},{"key":"5784_CR95","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1001\/archdermatol.2009.60","volume":"145","author":"AH Kalajian","year":"2009","unstructured":"Kalajian AH, Callen JP (2009) Myopathy Induced by Antimalarial agents: the relevance of screening muscle enzyme levels. Arch Dermatol 145:597\u2013600. https:\/\/doi.org\/10.1001\/archdermatol.2009.60","journal-title":"Arch Dermatol"},{"key":"5784_CR96","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1089\/rej.2011.1259","volume":"15","author":"G Li","year":"2012","unstructured":"Li G, Chen Y, Hu H et al (2012) Association between Age-Related decline of kidney function and plasma Malondialdehyde. Rejuvenation Res 15:257\u2013264. https:\/\/doi.org\/10.1089\/rej.2011.1259","journal-title":"Rejuvenation Res"},{"key":"5784_CR97","doi-asserted-by":"publisher","first-page":"101151","DOI":"10.1016\/j.arr.2020.101151","volume":"63","author":"Y Fang","year":"2020","unstructured":"Fang Y, Gong AY, Haller ST et al (2020) The ageing kidney: molecular mechanisms and clinical implications. Ageing Res Rev 63:101151. https:\/\/doi.org\/10.1016\/j.arr.2020.101151","journal-title":"Ageing Res Rev"},{"key":"5784_CR98","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1007\/s12026-016-8892-9","volume":"65","author":"MZ Szab\u00f3","year":"2017","unstructured":"Szab\u00f3 MZ, Szodoray P, Kiss E (2017) Dyslipidemia in systemic lupus erythematosus. Immunol Res 65:543\u2013550. https:\/\/doi.org\/10.1007\/s12026-016-8892-9","journal-title":"Immunol Res"},{"key":"5784_CR99","doi-asserted-by":"publisher","first-page":"257","DOI":"10.2165\/00003088-199631040-00003","volume":"31","author":"J Ducharme","year":"1996","unstructured":"Ducharme J, Farinotti R (1996) Clinical pharmacokinetics and metabolism of Chloroquine. Clin-Pharmacokinet 31:257\u2013274. https:\/\/doi.org\/10.2165\/00003088-199631040-00003","journal-title":"Clin-Pharmacokinet"},{"key":"5784_CR100","doi-asserted-by":"publisher","first-page":"1117","DOI":"10.1002\/art.39011","volume":"67","author":"C Pagnoux","year":"2015","unstructured":"Pagnoux C, Qu\u00e9m\u00e9neur T, Ninet J et al (2015) Treatment of systemic necrotizing vasculitides in patients aged sixty-five years or older: results of a Multicenter, Open\u2010Label, Randomized Controlled Trial of corticosteroid and cyclophosphamide\u2013based induction therapy. Arthritis Rheumatol 67:1117\u20131127. https:\/\/doi.org\/10.1002\/art.39011","journal-title":"Arthritis Rheumatol"}],"container-title":["Rheumatology International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-024-05784-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00296-024-05784-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-024-05784-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,24]],"date-time":"2025-01-24T06:39:58Z","timestamp":1737700798000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00296-024-05784-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,15]]},"references-count":100,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,1]]}},"alternative-id":["5784"],"URL":"https:\/\/doi.org\/10.1007\/s00296-024-05784-1","relation":{},"ISSN":["1437-160X"],"issn-type":[{"value":"1437-160X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,15]]},"assertion":[{"value":"13 November 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 December 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 January 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"None declared.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"29"}}